2018-2024年法国高疫苗接种覆盖率下幼儿侵袭性b型流感嗜血杆菌病增加
法国2018-2024年5岁以下儿童侵袭性b型流感嗜血杆菌(Hib)病发病率上升,2021年达峰值46例(1.4/10万儿童),共报告181例。6-11月龄病例中76.7%已正确接种两剂,≥12月龄病例中67.7%已正确接种三剂,三剂疫苗有效性估计为91.2%[95%CI 76.3-96.8%],不支持免疫力减弱。
要点
- 2018-2024年法国5岁以下儿童侵袭性Hib病增加,2021年峰值46例(1.4/10万)。
- 6-11月龄病例(n=60)中76.7%已正确接种两剂;≥12月龄病例(n=65)中67.7%已正确接种三剂。
- 三剂疫苗有效性估计为91.2%[95%CI 76.3-96.8%],不支持免疫力减弱。
核心结论
- 2018-2024年法国5岁以下儿童侵袭性Hib病增加,多数病例已正确接种疫苗,疫苗有效性估计不支持免疫力减弱,增加原因仍不确定。
研究设计与样本
- 基于法国国家流感嗜血杆菌参考中心的主动监测,纳入2018-2024年5岁以下经培养或PCR确诊的侵袭性Hib病病例,通过筛查法估计2-4岁儿童三剂疫苗有效性。
主要发现
- 2018-2024年共报告181例侵袭性Hib病病例,5岁以下儿童发病率上升,2021年峰值46例(1.4/10万儿童)。
- 6-11月龄病例(n=60)中76.7%已正确接种两剂;≥12月龄病例(n=65)中67.7%已正确接种三剂,共44例疫苗失败。
- 三剂疫苗有效性估计为91.2%[95%CI 76.3-96.8%]。
关键数值与推荐
- 疫苗失败定义为完成三剂系列接种后仍发生侵袭性Hib病。
- 三剂疫苗有效性估计为91.2%[95%CI 76.3-96.8%](2-4岁儿童,筛查法)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 侵袭性Hib病增加的原因仍不确定。
- 作者呼吁进一步研究两剂基础免疫后的疫苗有效性及疫苗接种对携带的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in France led to low invasive Hib disease incidence for two decades. In 2013, the vaccination schedule changed from 3+1 to 2+1 ((2, 4, and 11 months). Hib vaccination has been mandatory for children born since 2018. Despite vaccination coverage exceeding 95%, invasive Hib disease has increased since 2018. This study reports trends and characteristics of cases in mainland France from 2018 to 2024. METHODS: Cases were children under five years old with invasive Hib disease confirmed by culture or PCR by the National Reference Center for Haemophilus influenzae. Vaccination status was reported by biologists/clinicians or by regional investigation teams. Cases were described by age and vaccination status (unvaccinated, partially vaccinated, correctly vaccinated). Vaccine failure was defined as invasive Hib disease despite completion of the three-dose series. Vaccine effectiveness (VE) for three doses was estimated using the screening method in children aged 2-4 years. RESULTS: The incidence of invasive Hib disease among children under 5 years old increased during the 2018-2024 period, peaking in 2021 with 46 cases (1.4/100,000 children). From 2018 to 2024, 181 cases of invasive Hib disease were reported. Among those aged 6-11 months (n=60), 76.7% were correctly vaccinated with two doses. In children ≥12 months (n=65), 67.7% were correctly vaccinated with three doses and there were 44 vaccine failures. The estimated VE for three doses was 91.2% [95% confidence interval: 76.3-96.8%]. DISCUSSION - CONCLUSION: Invasive Hib disease increased among children under 5 years old in France during 2018-2024, and most cases were correctly vaccinated. VE estimate do not suggest waning immunity. The reasons that may explain the increase in invasive Hib cases remain uncertain. Our results call for further studies on the VE following the two primary doses and the impact of vaccination on carriage.
引用
- Barret AS, François C, Deghmane AE, et al. Increase in invasive Haemophilus influenzae type b disease in young children despite high vaccination coverage, France, 2018-2024. Vaccine. 2025. PMID: 40683138. doi:10.1016/j.vaccine.2025.127499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。